What is Capistrano Labs?
Capistrano Labs Incorporated operates at the intersection of advanced engineering and clinical diagnostics, specializing in high-fidelity ultrasound technology tailored for ophthalmology. The company provides a comprehensive suite of hardware solutions, including sophisticated ultrasound probes, thin-film transducers, and high-performance imaging engines. By functioning as a critical partner to the OEM community, Capistrano Labs delivers application-specific, PC-based imaging architectures that meet the rigorous demands of modern medical environments.
Beyond its core product offerings, the firm provides essential engineering services, contract manufacturing, and specialized repair solutions. This vertical integration allows the company to maintain stringent quality control over medical-grade components, ensuring that their imaging systems remain at the forefront of diagnostic accuracy. Their market position is defined by a commitment to technical excellence and a deep understanding of the specific requirements inherent in ophthalmic ultrasound system design.
How much funding has Capistrano Labs raised?
Capistrano Labs has raised a total of $435K across 2 funding rounds:
Debt
$150K
Debt
$285K
Debt (2020): $150K with participation from PPP
Debt (2021): $285K led by PPP
Key Investors in Capistrano Labs
PPP
Public-Private Partnership
What's next for Capistrano Labs?
With the recent influx of capital, Capistrano Labs is poised to accelerate its strategic initiatives, focusing on the refinement of its imaging engine technology and the expansion of its contract manufacturing services. The company is expected to prioritize the optimization of its supply chain to better serve its OEM partners, ensuring that its thin-film transducer technology remains a benchmark for the industry.
Looking ahead, the firm will likely leverage this financial stability to explore new diagnostic applications and enhance its service-oriented business model. By maintaining its focus on high-quality, application-specific solutions, Capistrano Labs is set to reinforce its role as a foundational player in the medical imaging ecosystem, driving innovation in ophthalmic care while maintaining the operational agility required for long-term market leadership.
